Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments

Journal of Clinical Microbiology

Volumn 47, Issue 10, 2009, Pages 3333-3335

  Wesolowski, Laura G ^a,c   Ethridge, Steven F ^a   Martin, Eugene G ^b   Cadoff, Evan M ^b   MacKellar, Duncan A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; TEMPERATURE SENSITIVITY; VIRUS EXAMINATION;

HEALTH SERVICES RESEARCH; HIV; HIV INFECTIONS; HUMANS; PUBLIC HEALTH; QUALITY ASSURANCE, HEALTH CARE; TECHNOLOGY, MEDICAL; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70349634903     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01504-09     Document Type: Article

References (13)

1. Reference deleted.
2. Reference deleted.
3. Centers for Disease Control and Prevention. 2007. CLIA certificate of waiver fact sheet. CDC, Atlanta, GA. http://www.cdc.gov/hiv/topics/testing/ resources/factsheets/roltCLIA.htm. Accessed 30 April 2008.
4. Centers for Disease Control and Prevention. 2007. Quality assurance guidelines for testing using rapid HIV antibody tests waived under the Clinical Laboratory Improvement Amendments of 1988. CDC, Atlanta, GA. http://www.cdc.gov/hiv/topics/testing/resources/guidelines/pdf/QA-Guidlines.pdf. Accessed 11 November 11 2008.
5. Delaney, K. P., B. M. Branson, A. Uniyal, P. R. Kerndt, P. A. Keenan, K. Jafa, A. D. Gardner, D. J. Jamieson, and M. Butlerys. 2006. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 20:1655-1660.
6. Granade, T. C., B. S. Parekh, S. K. Phillips, and J. S. McDougal. 2004. Performance of the OraQuick and Hema-Strip rapid HIV antibody detection assays by non-laboratorians. J. Clin. Virol. 30:229-232.
7. Greenwald, J. L., G. R. Burstein, J. Pincus, and B. Branson. 2006. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep. 8:125-131.
8. Jafa, K., P. Patel, D. A. MacKellar, P. S. Sullivan, K. P. Delaney, T. L. Sides, A. P. Newman, S. M. Paul, E. M. Cadoff, E. G. Martin, P. A. Keenan, and B. M. Branson for the OraQuick Study Group. 2007. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE 2:e185. doi:10.1371/journal.pone.0000185.
9. Learmonth, K. M., D. A. McPhee, D. K. Jardine, S. K. Walker, T.-T. Aye, and E. M. Dax. 2008. Assessing interpretation proficiency of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring the quality of testing. J. Clin. Microbiol. 46:1692-1697.
10. Orasure Technologies, Inc. 2002. OraQuick rapid HIV-1 antibody test package insert. Orasure Technologies, Inc., Bethlehem, PA.
11. Orasure Technologies, Inc. 2004. OraQuick Advance rapid HIV-1/2 antibody test package insert. Orasure Technologies, Inc., Bethlehem, PA.
12. Orasure Technologies, Inc. 2004. OraQuick Advance rapid HIV-1/2 antibody test kit controls package insert. Orasure Technologies, Inc., Bethlehem, PA.
13. Wesolowski, L. G., D. A. MacKellar, S. N. Facente, T. Dowling, S. F. Ethridge, J. H. Zhu, and P. S. Sullivan for the Post-Marketing Surveillance Team. 2006. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 20:1661-1666.